Guru Ownership Trend
Guru Analysis for Zevra Therapeutics, Inc. (ZVRA)
Zevra Therapeutics, Inc. (ZVRA), a key player in the Healthcare sector, continues to attract institutional attention.
As of Q3 2026, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $9.46 M.
Top institutional holders include Chuck Royce and Cliff Asness.
Institutional sentiment is currently Slightly Bearish. This is evidenced by a $5.88 M net outflow during the quarter.
Recent activity highlights Joel Greenblatt who opened a new position. Conversely, Cliff Asness reduced exposure by 28.7%.
Key Holders
Top 5 by Value
Top 5 by Conviction
Recent Activity Breakdown (Q3 2026)
Guru Consensus (Q3 2026)
FAQs for Zevra Therapeutics, Inc. (ZVRA)
Major holders include Chuck Royce ($9.97 M), Cliff Asness ($1.49 M), Joel Greenblatt ($381,657). According to the latest reported data, 3 tracked investment managers collectively hold approximately 1.08 M shares.
According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $5.88 M, with 2 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited ZVRA. The total reported sell value was $6.55 M.
Yes, 1 managers opened new positions in ZVRA, and 1 increased their existing holdings. The total reported buy value was $672,131.63.